The Trillium Therapeutics brand, founded in 2004 (Canada), from 1125 sister brands and 17477 competing brands. Trillium Therapeutics's notoriety arose from exemplary management which optimizes product quality and client satisfaction, which in turn generate financial performance, and therefore, stock performance. Being a Popular brand online is assessed based on the evolution of worldwide Web searches over the last five years.

Trillium Therapeutics is a brand of Pfizer Inc (PFE) Popularity

Buy Pfizer Inc share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
The following interest graph for Trillium Therapeutics shows the evolution of worldwide Web searches in the last five years. The graph shows the evolution of Trillium Therapeutics search rates over time, with a value of 100 indicating the month when it was highest.
Evolution of interest in the search “Trillium Therapeutics” (Google Trends)
Sources: Google Trends and Allbrands.markets
Compare the 5-year Web notoriety graph with the 5-year market price graph:
Notoriety -> Market prices